FTY-720
Cladribine still set to be first oral MS treatment
January 18, 2010Sales and Marketing Cladribine, FTY-720, MS, Merck Serono
Merck Serono’s new oral treatment for multiple sclerosis cladribine is still tipped to reach the market ahead of its rival, …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
